Vanda says EU grants orphan drug status to imsidolimab for generalized pustular psoriasisPUBT·2 hours agoVNDA-0.76%
NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. | VNDA Stock NewsStockTitan·2 days ago, 06:16 AMVNDA-0.76%
Vanda Pharmaceuticals' (VNDA) Buy Rating Reaffirmed at B. Riley FinancialMarket Beat·Aug 10 at 12:36 PMVNDA-0.76%
Vanda Pharma | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 50.53 MEarnings Watch·Aug 5 at 09:58 PMVNDA-0.76%
Vanda Q2 2026 Earnings: Fanapt Growth Could Not Prevent a Wider LossTradingKey·Aug 5 at 03:25 PMVNDA-0.76%
VNDA: Fanapt® sales surged, BYSANTI™ gained FDA approval, and NEREUS™ launched in Q2 2026Quartr·Aug 5 at 03:10 PMVNDA-0.76%
16:01 ETVanda Pharmaceuticals Reports Second Quarter 2026 Financial Resultsprnewswire·Aug 5 at 03:03 PMVNDA-0.76%
Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026 | VNDA Stock NewsStockTitan·Jul 29 at 07:31 AMVNDA-0.76%
